Skip to main content
. 2011 Jan 21;15(1):R35. doi: 10.1186/cc9983

Figure 2.

Figure 2

Blood glucose. When compared to placebo glucagon-like peptide-1 (GLP-1) caused a reduction in blood glucose at the end of the study (* at t = 270 minutes: GLP-1: 11.1 ± 1.1 vs. placebo: 12.6 ± 1.2; P = 0.02) and ameliorated glycaemia throughout the entire postpyloric nutrient infusion (** AUC30 to 270 minute: GLP-1 2,244 ± 184 vs. placebo 2,679 ± 233 mmol/l/minute; P = 0.02).